Exploration and Practice of Management Models for Clinical Application of National Essential Medicines

Journal: Journal of Clinical Medicine Research DOI: 10.32629/jcmr.v5i3.2786

Li Li, Gao Han, Jing Li, Lu Cao, Peng Zhang

Pharmacy Department, Shaanxi Provincial People's Hospital, Xi'an, Shaanxi, China

Abstract

Objective: To explore the role of the management model for the clinical application of national essential medicines in the management of essential drugs in our hospital. Methods: A management model for the clinical application of national essential medicines was established in our hospital. Under this management model, the allocation of essential medicines in our hospital was analyzed. Results: With the support of the management model for the clinical application of national essential medicines, our hospital successfully screened and introduced 34 specifications of national essential medicines in 2024. Additionally, five non-essential medicine specifications were replaced with essential medicines, increasing the proportion of essential medicines in our hospital by 16.77%. Conclusion: The management model for the clinical application of national essential medicines can effectively and sustainably promote the optimal allocation of the hospital's essential drug list, rational clinical use, and refined management of essential medicines.

Keywords

national essential medicines; management model; optimal allocation.

Full Text

PDF - Viewed/Downloaded: 0 Times

References

[1] National Health and Family Planning Commission, National Development and Reform Commission. Notice on the Issuance of the National Essential Medicines List Management Measures[S]. Guowei Yaozhengfa [2015] No. 52, February 13, 2015.
[2] Liu X., Tan N.N., Luo Y. Analysis of Research Progress on the National Essential Medicines System Based on Knowledge Mapping[J]. Smart Health, 2024, 10(2): 55-59.
[3] Ning Y.Y. Reflecting on the Original Intent and Re-examining the Essential Medicines System[J]. China Health, 2020, (10): 89-92.
[4] Shen W.W., Chen X., Tang B., Tian J.J., Wang X.J. Study on the Procurement of National Essential Medicines in Five Public Hospitals in Huainan Region[J]. Northwest Pharmacy Journal, 2024, 39(2): 241-246.
[5] Qiu Z.G., Ke L., Wan Y.S., Deng B., Zhou Z.S., Luo L., You R.X., Lu Y.N. Study on the Accessibility and Influencing Factors of National Medical Insurance Negotiation Drugs in a Certain Hospital[J]. Chinese Journal of Hospital Pharmacy, 2022, 42(18): 1918-1922.
[6] Wang T.L., Liu C.B., Cai L., Cao F., Liang J.M., Liu M., Chen M.L., Fan L. Analysis of the Use of Essential Medicines in Elderly Patients with Common Chronic Diseases[J]. Journal of Clinical Drug Therapy, 2024, 22(3): 26-30.
[7] Wang C.C. Analysis of Adverse Reactions Reports of National Essential Medicines in a Certain Hospital[J]. China Pharmacoeconomics, 2023, 18(12): 41-44.

Citing this article:

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License